George A. Samuel Iii Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

George A. Samuel Iii is General Counsel of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 25,820 shares of LCTX, which is worth approximately $14,459. The most recent transaction as insider was on Feb 11, 2025, when has been sold 2,440 shares (Common Shares) at a price of $0.65 per share, resulting in proceeds of $1,586. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K

16.39% 3M change

259.41% 12M change

Total Value Held $14,459

George A. Samuel III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	SELL Payment of exercise price or tax liability	$1,586 $0.65 p/Share	2,440 Reduced 8.63%	25,820 Common Shares
Feb 11 2025	BUY Exercise of conversion of derivative security	-	6,076 Added 17.7%	28,260 Common Shares
Nov 26 2024	BUY Open market or private purchase	$9,000 $0.6 p/Share	15,000 Added 40.34%	22,184 Common Shares
Feb 11 2024	SELL Payment of exercise price or tax liability	$2,689 $1.08 p/Share	2,490 Reduced 25.74%	7,184 Common Shares, no par ...
Feb 11 2024	BUY Exercise of conversion of derivative security	-	6,076 Added 38.58%	9,674 Common Shares, no par ...
Feb 11 2023	SELL Payment of exercise price or tax liability	$3,345 $1.35 p/Share	2,478 Reduced 40.78%	3,598 Common Shares, no par ...
Feb 11 2023	BUY Exercise of conversion of derivative security	-	6,076 Added 50.0%	6,076 Common Shares, no par ...

GAS

George A. Samuel Iii

General Counsel

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Value

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX

Account